ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
9.07
+0.23 (2.66%)
Mar 4, 2026, 10:57 AM EST - Market open

ClearPoint Neuro Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-23.14-18.91-22.09-16.44-14.41-6.78
Depreciation & Amortization
0.810.980.630.240.160.33
Stock-Based Compensation
7.96.916.084.132.081.09
Other Adjustments
2.060.682.020.191.160.24
Change in Receivables
-0.55-1.21-1.8-0.21-0.66-0.82
Changes in Inventories
0.290.741.25-4.42-1.71-0.03
Changes in Accounts Payable
0.483.11-0.651.591.29-0.46
Changes in Unearned Revenue
0.76-0.61.70.520.17-0.44
Changes in Other Operating Activities
-1.66-0.65-0.85-1.76-0.76-0.95
Operating Cash Flow
-13.09-8.95-13.72-16.17-12.7-7.81
Capital Expenditures
-0.74-0.28-0.72-0.25-0.17-0.04
Purchases of Intangible Assets
---0.33-0.89--0.44
Purchases of Investments
----21.59--
Proceeds from Sale of Investments
--1012--
Investing Cash Flow
-0.74-0.288.95-10.74-0.17-0.48
Short-Term Debt Issued
-----0.9
Net Short-Term Debt Issued (Repaid)
-----0.9
Long-Term Debt Issued
14.33----24.26
Long-Term Debt Repaid
--10----2.84
Net Long-Term Debt Issued (Repaid)
14.33-10---21.42
Issuance of Common Stock
3.7416.610.510.7547.470.38
Repurchase of Common Stock
-1.75-0.42-0.21-0.34-0.6-
Net Common Stock Issued (Repurchased)
216.190.30.4146.880.38
Other Financing Activities
-0.08-----
Financing Cash Flow
30.656.190.30.4146.8822.69
Net Cash Flow
-1.7-3.04-4.48-26.4934.0114.4
Free Cash Flow
-13.82-9.23-14.44-16.42-12.87-7.85
FCF Margin
-40.27%-29.39%-60.27%-79.90%-78.93%-61.17%
Free Cash Flow Per Share
-0.49-0.34-0.59-0.68-0.62-0.50
Levered Free Cash Flow
-8.88-25.6-20.73-20.52-15.4513.96
Unlevered Free Cash Flow
-22.78-16.44-21.09-20.42-14.41-7.8
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q